News from the FDA/CDC

New device that treats esophageal atresia in infants has been authorized


 

The FDA has authorized a medical device to treat infants up to age 1 year for esophageal atresia, called the Flourish Pediatric Esophageal Atresia Anastomosis.

The device uses magnets attached to two catheters to pull the upper and lower esophagus together, closing the gap for several days until a connection is formed. The catheters are then removed, and the infant can begin feeding via mouth.

“This new device provides a nonsurgical option for doctors to treat esophageal atresia in babies born with this condition,” said William Maisel, MD, MPH, acting director of the FDA’s Office of Device Evaluation. “But it is only intended for infants who do not have a tracheoesophageal fistula or who have had the fistula repaired in a prior surgery.”

Cook Medical provided data on 16 patients implanted with Flourish devices. All patients had successful joining of their esophagus within 3-10 days after receiving the device. A total of 13 of the 16 patients developed anastomotic stricture that required a balloon dilation procedure, a stent, or both to repair. Such strictures also occur with traditional surgery.

The Flourish device should not be used in patients older than 1 year. Other potential complications that may occur include stomach or mouth irritation near the catheter insertion sites and gastroesophageal reflux.

Learn more about the study at www.fda.gov/newsevents/newsroom/pressannouncements/ucm558241.htm.

Recommended Reading

Racial, ethnic differences exist ADHD treatment of Medicaid-enrolled youth
MDedge Pediatrics
Asthma step-up therapy in children improves outcomes
MDedge Pediatrics
Study supports link between pediatric MS and remote viral infections
MDedge Pediatrics
Intravenous tPA ups mortality in children with acute ischemic stroke
MDedge Pediatrics
Nausea with pediatric functional abdominal pain may mean depression, anxiety
MDedge Pediatrics
FDA: Some blood lead tests have reported falsely low levels since 2014
MDedge Pediatrics
HPV vaccine training video improved provider knowledge, confidence
MDedge Pediatrics
Adalimumab outperforms methotrexate in treating severe pediatric plaque psoriasis
MDedge Pediatrics
Preterm infants at high risk for RSV morbidity without immunoprophylaxis
MDedge Pediatrics
Marijuana-related visits to Colorado ED steadily increasing
MDedge Pediatrics